FDA restricts J&J's COVID-19 vaccine due to blood clot risk

compartilhou um link

2022-05-09 05:39:20 -

https://apnews.com/article/covid-science-business-health-11b4f26de57da9b1b62669c1b2394ab3

WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J's vaccine.

0 Comentários 0 Compartilhamentos 52 Visualizações